AU5949773A - Tge virus vaccine - Google Patents

Tge virus vaccine

Info

Publication number
AU5949773A
AU5949773A AU59497/73A AU5949773A AU5949773A AU 5949773 A AU5949773 A AU 5949773A AU 59497/73 A AU59497/73 A AU 59497/73A AU 5949773 A AU5949773 A AU 5949773A AU 5949773 A AU5949773 A AU 5949773A
Authority
AU
Australia
Prior art keywords
virus vaccine
tge virus
tge
vaccine
virus
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
AU59497/73A
Inventor
Deam H Ferris
Angel S Arambulo
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Illinois
University of Illinois Foundation
Original Assignee
University of Illinois
University of Illinois Foundation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US00285036A external-priority patent/US3823228A/en
Application filed by University of Illinois, University of Illinois Foundation filed Critical University of Illinois
Publication of AU5949773A publication Critical patent/AU5949773A/en
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/215—Coronaviridae, e.g. avian infectious bronchitis virus
    • A61K39/225—Porcine transmissible gastroenteritis virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/167—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface
    • A61K9/1676—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface having a drug-free core with discrete complete coating layer containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5254—Virus avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541—Mucosal route
    • A61K2039/542—Mucosal route oral/gastrointestinal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/545—Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/20011—Coronaviridae
    • C12N2770/20034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Microbiology (AREA)
  • Communicable Diseases (AREA)
  • Immunology (AREA)
  • Mycology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pulmonology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
AU59497/73A 1972-08-30 1973-08-22 Tge virus vaccine Expired AU5949773A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US00285036A US3823228A (en) 1971-09-29 1972-08-30 Tge virus vaccine

Publications (1)

Publication Number Publication Date
AU5949773A true AU5949773A (en) 1975-02-27

Family

ID=23092469

Family Applications (1)

Application Number Title Priority Date Filing Date
AU59497/73A Expired AU5949773A (en) 1972-08-30 1973-08-22 Tge virus vaccine

Country Status (9)

Country Link
JP (1) JPS535371B2 (en)
AR (1) AR197158A1 (en)
AU (1) AU5949773A (en)
CA (1) CA1023266A (en)
DE (1) DE2343570A1 (en)
FR (1) FR2197576B1 (en)
GB (1) GB1440214A (en)
NL (1) NL7312032A (en)
PH (1) PH10296A (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0009577A1 (en) * 1978-08-18 1980-04-16 Burns-Biotec Laboratories Inc. An oral vaccine preparation and a method for increasing the resistance of swine to swine-dysentery infection
JPS584561Y2 (en) * 1980-11-26 1983-01-26 日本濾過器株式会社 bubble separator
DK150008C (en) * 1981-11-20 1987-05-25 Benzon As Alfred PROCEDURE FOR THE PREPARATION OF A PHARMACEUTICAL ORAL POLYDEPOT PREPARATION
US5811128A (en) * 1986-10-24 1998-09-22 Southern Research Institute Method for oral or rectal delivery of microencapsulated vaccines and compositions therefor
DE19741114C2 (en) * 1997-09-12 2002-10-24 Riemser Arzneimittel Ag Moisture-stable and enteric drug form for fish

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3458621A (en) * 1966-08-31 1969-07-29 American Home Prod Tablet dosage-form for the immunization of the intestinal tract with live virus preparations
US3519710A (en) * 1967-08-10 1970-07-07 Edmund P Bass Direct active modified live virus vaccine immunization against transmissible gastroenteritis in swine piglets at birth

Also Published As

Publication number Publication date
AR197158A1 (en) 1974-03-15
PH10296A (en) 1976-11-10
FR2197576B1 (en) 1976-09-03
NL7312032A (en) 1975-03-04
DE2343570A1 (en) 1974-03-14
FR2197576A1 (en) 1974-03-29
JPS535371B2 (en) 1978-02-27
CA1023266A (en) 1977-12-27
JPS4962618A (en) 1974-06-18
GB1440214A (en) 1976-06-23

Similar Documents

Publication Publication Date Title
AU465353B2 (en)
BE787901A (en) ANTIVARIOLIC VACCINE
ZA711382B (en) Poultry vaccine
AU8440975A (en) E. coli vaccine
AU498810B2 (en) Influenza vaccines
AU5949773A (en) Tge virus vaccine
HK56380A (en) Influenza vaccines
IE35695L (en) Virus preparation
AU7096274A (en) Vaccine
IE35729B1 (en) Vaccine preparation
ZA735735B (en) Tge virus vaccine
AU465371B2 (en)
AT322091B (en) VACCINE
AU5047272A (en) Vaccine
AU2091370A (en) Improvements; in virus vaccines
CA916592A (en) Viral vaccines
AU4173472A (en) Vaccine
CA905848A (en) Vaccines
IL42749A0 (en) Influenza vaccine and its preparation
ZA732137B (en) Vaccines
AU4191272A (en) Axial-flow blower
AU463400B2 (en) Poultry vaccine
AU475697B2 (en)
AU6276973A (en) Syringe
IE35139B1 (en) Poultry vaccine